Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for PLX3397 (oral)

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBRE1246

    03/13/2015

    Enhancing Efficacy of Chemotherapy in Triple-Negative/Basal-Like Breast Cancers by Targeting Macrophages: A Phase Ib/II Study of PLX3397 and Eribulin in Patients with Metastatic Breast Cancer


    Print this page for your doctor